Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 408Rectal Neoplasms 152Colonic Neoplasms 150Pancreatic Neoplasms 114Stomach Neoplasms 110Neoplasm Metastasis 70Esophageal Neoplasms 60Esophageal Squamous Cell Carcinoma 33Neoplasms 31Adenocarcinoma Of Esophagus 27Gastrointestinal Neoplasms 17Cholangiocarcinoma 14Biliary Tract Neoplasms 14Gallbladder Neoplasms 12Carcinoma, Hepatocellular 12Adenocarcinoma 12Colorectal Cancer Metastatic 11Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Liver Neoplasms 10Digestive System Neoplasms 10Ovarian Neoplasms 9Small Cell Lung Carcinoma 8Locally Advanced Rectal Cancer 8Intestinal Neoplasms 8Bile Duct Neoplasms 8Carcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Digestive System Diseases 6Appendiceal Neoplasms 6

Interventions

pembrolizumab 5Nivolumab 5Ipilimumab 4avelumab 3Neoadjuvant Therapy 3toripalimab 2durvalumab 2atezolizumab 2Specimen Handling 2Immune Checkpoint Inhibitors 2Celecoxib 2tislelizumab 1spartalizumab 1sintilimab 1regorafenib 1fludarabine phosphate 1fludarabine 1danvatirsen 1camrelizumab 1Taxes 1Surgical Procedures, Operative 1Radiation Dose Hypofractionation 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Interleukin-2 1Immunoglobulin G 1IMM-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × Irinotecan × Gastrointestinal × Clear all
NCT05838768 2026-03-24

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Novartis

Phase 1 Active not recruiting
123 enrolled
Gastrointestinal

Turcot syndrome, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡